Search for: "Holman"
Results 461 - 480
of 747
Sorted by Relevance
|
Sort by Date
21 Apr 2023, 9:27 am
By Chris Holman Amgen Inc. v. [read post]
20 Jul 2022, 8:27 am
By Chris Holman A couple days ago Dennis posted a nice review of the Federal Circuit’s recent decision in CareDx v. [read post]
13 Apr 2017, 5:00 am
” “The word ‘genius’ tends to be over-used and is properly reserved for Leonardo Da Vinci, Mozart, Einstein, and others like them,” Justice Edward Holman said following the ruling Work decided to appeal Holman’s 2015 ruling. [read post]
5 Nov 2021, 8:20 am
Wendy Holman claimed in an interview that the company tried and failed to receive manufacturing funding from BARDA. [read post]
24 Sep 2009, 3:16 pm
It reasoned that its decision in the case of Holman v. [read post]
10 Jun 2010, 3:58 am
(Holman's Biotech IP Blog)(Patent Docs) (Patent Docs) Cenestin (Conjugated estrogens) US: Teva’s patent for Cenestin under threat due to file wrapper estoppel (IP Factor) Cipro (Ciprofloxacin) – US: Court of Appeals for the Second Circuit invites examination of reverse settlement agreements by the Full Court of Appeals (IP Whiteboard) Combivir (Lamivudine, Zidovudine) – US: GlaxoSmithKline and Teva reach settlement in Combivir dispute (Patent Docs) Cubicin… [read post]
8 Feb 2019, 10:30 am
Because the majority does not answer this argument in its brief order, I will copy the District Court's ruling, as quoted in the State's petition:Ray has been a death-row inmate at Holman Correctional Facility since 1999. [read post]
10 Sep 2021, 7:12 am
Holman said on Thursday. [read post]
5 Dec 2008, 1:00 pm
(Holman's Biotech IP Blog) IP and genetically modified organisms: a fateful combination, activists say (Intellectual Property Watch) Australia: Gene patent delays diagnosis and treatment for babies with severe form of epilepsy: (Techdirt) Brazil: Brazilian draft law would curb expanded patents on pharmaceuticals (Intellectual Property Watch) (IP tango) EU: European Commission issues preliminary report on its inquiry into competition in the pharmaceutical sector (IPKat) (Copyfight)… [read post]
8 Dec 2010, 2:20 am
PTO (Holman’s Biotech IP Blog) US: Myriad and the ACLU disagree over claim scope, but apparently not over patent eligibility of genetic diagnostic methods: AMP v. [read post]
28 Aug 2012, 11:06 am
Craig Holman, the government affairs lobbyist with Public Citizen, said this type of arrangement raises questions about whether lobbying rules are being broken. [read post]
16 May 2022, 11:40 am
Holman, who was just 13 when her brother was wrongly arrested, said she hopes that her brother will one day be free and will be among those at a future Innocence Project gala. [read post]
7 Nov 2008, 3:42 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: CAFC affirms rejection of claim reciting broad genus of monoclonal antibodies for failure to satisfy written description requirement: In re Alonso… [read post]
10 Aug 2010, 8:44 pm
Highlights this week included: CAFC: Genus-species; doctrine of equivalents; and patentable subject matter: Intervet v Merial Limited (Patently-O) (Holman’s Biotech IP Blog) (IP Spotlight) (IPBiz) (Patent Docs) Angiomax (Bivalirudin) – US: The Medicines Company prevails in patent term extension dispute; USPTO acts quickly to comply with court order (Patent Docs) (Patent Docs) (IPBiz) Skelaxin (Metaxalone) – US: CAFC: Ignoring non-patentable elements while judging… [read post]
8 May 2009, 8:00 am
(Property intangible) US: Supreme Court rules 9-0 that CAFC has jurisdiction to review case remanded by district court to state court: Carlsbad Technology Inc v HIF Bio, Inc et al (Managing Intellectual Property) (Patently-O) US: Anticipation by a laundry list of prophetic DNA sequences: In re Gleave (Holman's Biotech IP Blog) US: Reverse payment settlements and biotechnology (Holman's Biotech IP Blog) US: Biogen seeks review and correction of patent term adjustment… [read post]
14 Jul 2010, 6:47 pm
Cefetra (Holman’s Biotech IP Blog) (Patent Baristas) (Patent Docs) (IP Watch) (EPLAW) Germany : German parliament members seek limited patent terms in EU-India FTA (IP Watch) Netherlands: Sufficiency of disclosure finally on the Dutch radar : Novozymes v. [read post]
3 Nov 2010, 1:21 am
Pharmachemie (EPLAW) US: Supreme Court to hear Bayh-Dole patent ownership dispute: Stanford v Roche (Patently-O) (IPKat) (IPBiz) US: DoJ amicus brief in Myriad says no to patentability of genomic DNA: AMP v USPTO (IPBiz) (Inventive Step) (Patently-O) (Patent Docs) (Holman’s Biotech IP Blog) US: Briefing update: AMP v USPTO (Patent Docs) US: BIO and AUTM file amicus brief in Myriad case (PatentlyBIOtech) US: Myriad files appeal brief in AMP v USPTO (Patent Docs) US: Is it patentable? [read post]
19 May 2011, 9:53 am
Jason Oric Williams is scheduled to receive a lethal injection at 6 p.m. today at Holman Prison in Atmore. [read post]
11 May 2011, 4:54 am
ARUP: Genetic testing patents found to be anticipated and in violation of Lilly written description requirement (Holman’s Biotech IP Blog) (Patent Docs) (Patently-O) Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
26 Oct 2011, 2:30 am
Prometheus Labs (Patently-O) US: Pioneer-DuPont sues Monsanto for infringing “low tech” agricultural biotechnology patents (Holman’s Biotech IP Blog) Products Arzerra (Ofatumumab) / Rituxan (Rituximab)– US: Claim construction ruling in Arzerra infringement case: Biogen Idec and Genentech v. [read post]
